- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$164.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$48,000.00
7D
-1.6%
1Y
60.0%
Bristol-Myers Squibb
Market Cap: AR$115.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$28,160.00
7D
1.4%
1Y
54.1%
Amgen
Market Cap: US$181.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$11.45
7D
0.5%
1Y
36.3%
Biogen
Market Cap: AR$28.3b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$22,160.00
7D
0.4%
1Y
95.7%
Bristol-Myers Squibb
Market Cap: US$116.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$19.83
7D
1.3%
1Y
n/a
Bayer
Market Cap: AR$22.5b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Amgen
Market Cap: AR$181.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$16,150.00
7D
-1.8%
1Y
51.3%
Biogen
Market Cap: US$28.5b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$15.32
7D
-1.5%
1Y
54.0%
Novartis
Market Cap: AR$222.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$55,025.00
7D
1.1%
1Y
72.1%
GSK
Market Cap: US$74.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.08
7D
-0.5%
1Y
36.8%
Novartis
Market Cap: US$222.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$39.21
7D
7.2%
1Y
42.1%
Gilead Sciences
Market Cap: US$164.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$34.21
7D
-1.1%
1Y
26.7%
GSK
Market Cap: AR$74.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$18,410.00
7D
-1.8%
1Y
65.9%
Pfizer
Market Cap: AR$146.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
AR$9,380.00
7D
-1.5%
1Y
40.2%
Thermo Fisher Scientific
Market Cap: US$166.6b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMOD
US$20.83
7D
-8.0%
1Y
n/a
Vertex Pharmaceuticals
Market Cap: AR$114.3b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$6,445.00
7D
2.4%
1Y
n/a
Thermo Fisher Scientific
Market Cap: AR$166.6b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
AR$29,600.00
7D
-5.8%
1Y
34.7%
Pfizer
Market Cap: US$146.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFED
US$6.60
7D
-0.8%
1Y
14.2%
Vertex Pharmaceuticals
Market Cap: US$114.3b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$4.48
7D
1.4%
1Y
n/a